Senta Frol

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Venous Thromboembolism

Systematic Review

Top Venues

Neurology international

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Journal of thrombosis and thrombolysis

This page only lists publications with an associated author ORCID identifier.

Publications

Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Wim H van Zwam, George Ntaios, Karl Olof Lövblad, Andreas Gruber, Pawel Kermer
Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Maša Fabjan, Ana Jurečič, Miha Jerala, Janja Pretnar Oblak, Senta Frol
Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood. Neurology international 16 (2) (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data. CNS drugs (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data. CNS drugs 38 (3) (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Wim H van Zwam, George Ntaios, Karl Olof Lövblad, Andreas Gruber, Pawel Kermer
Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data. CNS drugs 38 (3) (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data. CNS drugs 38 (3) (2024)
Maša Fabjan, Ana Jurečič, Miha Jerala, Janja Pretnar Oblak, Senta Frol
Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood. Neurology international 16 (2) (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Wim H van Zwam, George Ntaios, Karl Olof Lövblad, Andreas Gruber, Pawel Kermer
Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Nina Žakelj, Igor Rigler, Alja Longo, Senta Frol, Janja Pretnar Oblak
Clinical outcomes of reperfusion therapy in patients with site-specific basilar artery occlusion. Journal of neurointerventional surgery (2024)
Maša Fabjan, Ana Jurečič, Miha Jerala, Janja Pretnar Oblak, Senta Frol
Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood. Neurology international 16 (2) (2024)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer, Matjaž Sever
Treatment of Acute Ischaemic Stroke and Concomitant Multiple Arterial Splanchnic Thromboses in a Patient with Immune Thrombocytopenia on Thrombopoietin Agonist: A Case Report. Neurology international 15 (3) (2023)
Senta Frol, Mišo Šabovič, Janja Pretnar Oblak
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature. CNS drugs 37 (2) (2023)
Senta Frol, Mišo Šabovič, Janja Pretnar Oblak
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature. CNS drugs (2023)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke. Journal of thrombosis and thrombolysis (2023)
Senta Frol, Mišo Šabovič, Janja Pretnar Oblak
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature. CNS drugs 37 (2) (2023)
Senta Frol, Mišo Šabovič, Janja Pretnar Oblak
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature. CNS drugs 37 (2) (2023)
Senta Frol, Mišo Šabovič, Janja Pretnar Oblak
Apixaban for the Treatment of Cerebral Venous Sinus Thrombosis: A Single-Centre Experience and Systematic Review of the Literature. CNS drugs 37 (2) (2023)
Slaven Pikija, Janja Pretnar-Oblak, Senta Frol, Branko Malojcic, Thomas Gattringer, Kinga Rak-Frattner, Dimitre Staykov, Andrea Salmaggi, Riccardo Milani, Jozef Magdic, Sarah Iglseder, Eugen Trinka, Theo Kraus, Andreea Toma, Jacopo C DiFrancesco, Payam Tabaee Damavandi, Natalia Fabin, Anna Bersano, Inés Albájar, Patricia de la Riva, Benedetta Storti, Author S Simon Fandler-Höfler
Iatrogenic cerebral amyloid angiopathy: A multinational case series and individual patient data analysis of the literature. International journal of stroke : official journal of the International Stroke Society (2023)
Matej Perovnik, Janja Pretnar Oblak, Senta Frol
A Case Series of Four Patients with Artery of Percheron Occlusion over a Three-Month Period. Neurology international 15 (4) (2023)
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage. CNS drugs (2023)
Senta Frol, Liam K Hudnik, Lana P Sernec, Mišo Šabovič, Katarina Šurlan Popovič, Janja Pretnar Oblak
Recurrent Strokes in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Agents. Angiology (2022)
Senta Frol, Lana Podnar Sernec, Liam Korošec Hudnik, Mišo Šabovič, Janja Pretnar Oblak
Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients. CNS drugs 35 (2) (2021)
Senta Frol, Liam Korošec Hudnik, Lana Podnar Sernec, Mišo Šabovič, Janja Pretnar Oblak
Direct oral anticoagulants for secondary stroke prevention in patients over 80 years of age: the role of geriatric functional status. Journal of thrombosis and thrombolysis (2021)
Senta Frol, Lana Podnar Sernec, Liam Korošec Hudnik, Mišo Šabovič, Janja Pretnar Oblak
Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention. Clinical drug investigation 40 (11) (2020)
Senta Frol, Mišo Šabovič, Janja Pretnar Oblak
Re-initiation of anticoagulation after central nervous system hemorrhage during treatment with direct oral anticoagulants: a single hospital cohort study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42 (5) (2020)